DK0981537T3 - Smitsom klon af humant parainfluenzavirus type 3 - Google Patents

Smitsom klon af humant parainfluenzavirus type 3

Info

Publication number: DK0981537T3
Authority: DK; Denmark
Prior art keywords: hpiv; clone; protein; nucleotide sequence; genome
Prior art date: 1997-05-07

Application number

DK98922118T

Other languages

Danish (da)

English (en)

Inventor

Amiya K Banerjee

Michael A Hoffman

Original Assignee

Cleveland Clinic Foundation

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-05-07

Filing date

1998-05-06

Publication date

2007-11-19

1998-05-06 Application filed by Cleveland Clinic Foundation filed Critical Cleveland Clinic Foundation

2007-11-19 Application granted granted Critical

2007-11-19 Publication of DK0981537T3 publication Critical patent/DK0981537T3/da

Links

241000712003 Human respirovirus 3 Species 0.000 title abstract 14
208000015181 infectious disease Diseases 0.000 title abstract 2
230000002458 infectious effect Effects 0.000 title abstract 2
239000002773 nucleotide Substances 0.000 abstract 5
125000003729 nucleotide group Chemical group 0.000 abstract 5
108090000623 proteins and genes Proteins 0.000 abstract 3
102000004169 proteins and genes Human genes 0.000 abstract 3
101001065501 Escherichia phage MS2 Lysis protein Proteins 0.000 abstract 2
238000000034 method Methods 0.000 abstract 2
102000053642 Catalytic RNA Human genes 0.000 abstract 1
108090000994 Catalytic RNA Proteins 0.000 abstract 1
102000004163 DNA-directed RNA polymerases Human genes 0.000 abstract 1
108090000626 DNA-directed RNA polymerases Proteins 0.000 abstract 1
101900161954 Human parainfluenza 3 virus Phosphoprotein Proteins 0.000 abstract 1
108091028043 Nucleic acid sequence Proteins 0.000 abstract 1
102100034574 P protein Human genes 0.000 abstract 1
101710181008 P protein Proteins 0.000 abstract 1
208000002606 Paramyxoviridae Infections Diseases 0.000 abstract 1
101710177166 Phosphoprotein Proteins 0.000 abstract 1
241000700605 Viruses Species 0.000 abstract 1
230000015572 biosynthetic process Effects 0.000 abstract 1
238000012258 culturing Methods 0.000 abstract 1
230000035772 mutation Effects 0.000 abstract 1
108091092562 ribozyme Proteins 0.000 abstract 1
238000003786 synthesis reaction Methods 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/10—Cells modified by introduction of foreign genetic material
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18611—Respirovirus, e.g. Bovine, human parainfluenza 1,3
- C12N2760/18621—Viruses as such, e.g. new isolates, mutants or their genomic sequences
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18611—Respirovirus, e.g. Bovine, human parainfluenza 1,3
- C12N2760/18622—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18611—Respirovirus, e.g. Bovine, human parainfluenza 1,3
- C12N2760/18634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18611—Respirovirus, e.g. Bovine, human parainfluenza 1,3
- C12N2760/18651—Methods of production or purification of viral material
- C12N2760/18652—Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Genetics & Genomics (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Zoology (AREA)
Wood Science & Technology (AREA)
Bioinformatics & Cheminformatics (AREA)
Biomedical Technology (AREA)
General Health & Medical Sciences (AREA)
Biochemistry (AREA)
Biotechnology (AREA)
General Engineering & Computer Science (AREA)
Virology (AREA)
Molecular Biology (AREA)
Medicinal Chemistry (AREA)
Microbiology (AREA)
Biophysics (AREA)
Gastroenterology & Hepatology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Immunology (AREA)
Physics & Mathematics (AREA)
Plant Pathology (AREA)
Cell Biology (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

DK98922118T 1997-05-07 1998-05-06 Smitsom klon af humant parainfluenzavirus type 3 DK0981537T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US4580597P	1997-05-07	1997-05-07
PCT/US1998/009270 WO1998050405A1 (fr)	1997-05-07	1998-05-06	Clone infectieux associe au virus parainfluenza de type 3 d'origine humaine

Publications (1)

Publication Number	Publication Date
DK0981537T3 true DK0981537T3 (da)	2007-11-19

Family

ID=21939986

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK98922118T DK0981537T3 (da)	1997-05-07	1998-05-06	Smitsom klon af humant parainfluenzavirus type 3

Country Status (15)

Country	Link
US (1)	US6248578B1 (fr)
EP (1)	EP0981537B1 (fr)
JP (1)	JP2002512519A (fr)
KR (2)	KR100585946B1 (fr)
CN (1)	CN1208340C (fr)
AT (1)	ATE367397T1 (fr)
AU (1)	AU736586B2 (fr)
BR (1)	BR9809240A (fr)
CA (1)	CA2289776C (fr)
CY (1)	CY1107730T1 (fr)
DE (1)	DE69838097T2 (fr)
DK (1)	DK0981537T3 (fr)
ES (1)	ES2289782T3 (fr)
PT (1)	PT981537E (fr)
WO (1)	WO1998050405A1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7465574B2 (en)	1994-09-30	2008-12-16	Medimmune, Llc	Recombinant RSV virus expression systems and vaccines
US6830748B1 (en)	1997-09-26	2004-12-14	Medimmune Vaccines, Inc.	Recombinant RSV virus expression systems and vaccines
US6764685B1 (en) *	2000-03-21	2004-07-20	Medimmune Vaccines, Inc.	Recombinant parainfluenza virus expression systems and vaccines
CN1646684B (zh) *	2002-02-21	2010-10-06	免疫医疗疫苗公司	重组副流感病毒表达系统以及包含源自间质肺病毒的异种抗原的疫苗
US20100316991A1 (en) *	2009-06-11	2010-12-16	Utah State University	Human parainfluenza virus type 3 expressing the enhanced green fluorescent protein for use in high-throughput antiviral assays
CN118930643B (zh) *	2024-08-20	2025-02-18	苏州东抗生物科技有限公司	副流感3型np蛋白抗体6d3

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5166057A (en)	1989-08-28	1992-11-24	The Mount Sinai School Of Medicine Of The City University Of New York	Recombinant negative strand rna virus expression-systems
PT702085E (pt)	1994-07-18	2004-04-30	Karl Klaus Conzelmann	Virus de arn de cadeia negativa nao segmentada infeccioso recombinante
US5869036A (en) *	1995-12-08	1999-02-09	St. Louis University	Live attenuated vaccines based on CP45 HPIV-3 strain and method to ensure attenuation in such vaccine

1998
- 1998-05-06 JP JP54846598A patent/JP2002512519A/ja active Pending
- 1998-05-06 ES ES98922118T patent/ES2289782T3/es not_active Expired - Lifetime
- 1998-05-06 KR KR1019997010246A patent/KR100585946B1/ko not_active Expired - Fee Related
- 1998-05-06 KR KR1020067002175A patent/KR100678818B1/ko not_active Expired - Fee Related
- 1998-05-06 AU AU74731/98A patent/AU736586B2/en not_active Ceased
- 1998-05-06 DE DE69838097T patent/DE69838097T2/de not_active Expired - Fee Related
- 1998-05-06 AT AT98922118T patent/ATE367397T1/de not_active IP Right Cessation
- 1998-05-06 PT PT98922118T patent/PT981537E/pt unknown
- 1998-05-06 WO PCT/US1998/009270 patent/WO1998050405A1/fr not_active Ceased
- 1998-05-06 CA CA002289776A patent/CA2289776C/fr not_active Expired - Fee Related
- 1998-05-06 EP EP98922118A patent/EP0981537B1/fr not_active Expired - Lifetime
- 1998-05-06 DK DK98922118T patent/DK0981537T3/da active
- 1998-05-06 BR BR9809240-5A patent/BR9809240A/pt not_active Application Discontinuation
- 1998-05-06 US US09/073,492 patent/US6248578B1/en not_active Expired - Fee Related
- 1998-05-06 CN CNB988048833A patent/CN1208340C/zh not_active Expired - Fee Related
2007
- 2007-09-10 CY CY20071101163T patent/CY1107730T1/el unknown

Also Published As

Publication number	Publication date
DE69838097D1 (de)	2007-08-30
ATE367397T1 (de)	2007-08-15
CN1255140A (zh)	2000-05-31
KR100585946B1 (ko)	2006-06-07
WO1998050405A1 (fr)	1998-11-12
KR20060014461A (ko)	2006-02-15
KR20010012294A (ko)	2001-02-15
CY1107730T1 (el)	2013-04-18
CN1208340C (zh)	2005-06-29
HK1025973A1 (en)	2000-12-01
PT981537E (pt)	2007-10-16
BR9809240A (pt)	2000-06-27
US6248578B1 (en)	2001-06-19
AU736586B2 (en)	2001-08-02
EP0981537B1 (fr)	2007-07-18
EP0981537A1 (fr)	2000-03-01
DE69838097T2 (de)	2008-04-10
JP2002512519A (ja)	2002-04-23
CA2289776A1 (fr)	1998-11-12
KR100678818B1 (ko)	2007-02-07
ES2289782T3 (es)	2008-02-01
EP0981537A4 (fr)	2002-09-18
AU7473198A (en)	1998-11-27
CA2289776C (fr)	2008-10-21

Publication	Publication Date	Title
Galinski et al.	1992	RNA editing in the phosphoprotein gene of the human parainfluenza virus type 3
Fodor et al.	1999	Rescue of influenza A virus from recombinant DNA
Radecke et al.	1996	The nonstructural C protein is not essential for multiplication of Edmonston B strain measles virus in cultured cells
Van Der Werf et al.	1986	Synthesis of infectious poliovirus RNA by purified T7 RNA polymerase.
Buchholz et al.	1999	Generation of bovine respiratory syncytial virus (BRSV) from cDNA: BRSV NS2 is not essential for virus replication in tissue culture, and the human RSV leader region acts as a functional BRSV genome promoter
Garcia-Sastre et al.	1994	Use of a mammalian internal ribosomal entry site element for expression of a foreign protein by a transfectant influenza virus
Meyer et al.	1995	The nucleotide sequence of the fusion protein gene of the peste des petits ruminants virus: the long untranslated region in the 5′-end of the F-protein gene of morbilliviruses seems to be specific to each virus
Schneider et al.	1997	Rescue of measles virus using a replication-deficient vaccinia-T7 vector
Barrett et al.	1985	Nucleotide sequence of the entire protein coding region of canine distemper virus polymerase-associated (P) protein mRNA
DE69840361D1 (de)	2009-01-29	Neue knochenmineralisierungsproteine, dna, vektoren, expressionssysteme
DK1056873T3 (da)	2010-07-26	Fremgangsmåder til produktion af et polypeptid i en Bacillus-celle
FI932678A7 (fi)	1993-07-27	Alfaviruksiin perustuvia DNA-ilmentämissysteemejä
Calain et al.	1995	Functional characterisation of the genomic and antigenomic promoters of Sendai virus
JP2007502623A (ja)	2007-02-15	膜タンパク質におけるフリンプロテアーゼ開裂部位の挿入およびその使用法
CN101517079A (zh)	2009-08-26	非复制型副粘病毒科病毒载体
ATE309367T1 (de)	2005-11-15	Nukleotid- und aminosäuresequenzen der gene des hüllproteins 1 und des kernproteins von hepatitis c virus
ATE414146T1 (de)	2008-11-15	Methoden zur herstellung von helpervirusfreien präparationen von freien rekombinenten aav- vektoren mit hohem titer
CY1107730T1 (el)	2013-04-18	Μολυσματικος κλωνος για ιο ανθρωπινης παραγριππης τυπου 3
Johnston et al.	1999	A recombinant measles vaccine virus expressing wild-type glycoproteins: consequences for viral spread and cell tropism
ES8600403A1 (es)	1985-09-16	Un procedimiento para producir un peptido que comprende un peptido de exo-senal unido operativamente a una proteina deseada
Leyrer et al.	1998	Rapid and efficient recovery of Sendai virus from cDNA: factors influencing recombinant virus rescue
ID27206A (id)	2001-03-08	Generasi produk-produk perbanyakan gena dari protein-protein fusi simerik melalui pemutusan endoprotease ubikuitus
CA2333313A1 (fr)	1999-12-09	Nouveau procede pour recuperer des virus a arn
Komarova et al.	2013	Identification of RNA partners of viral proteins in infected cells
WO2002074960A3 (fr)	2003-09-12	Methodes et compositions relatives aux proteines humaines 38650, 28472, 5495, 65507, 81588 et 14354 et leurs utilisations